bevacizumab,trifluridine tipiracil
roche,otsuka,taiho pharma
[]
dr. deming discussant on ph iii sunlight #tas102 + bev superior to active control tas102 (median os 10.8 vs 7.5 mos) in unselected #3l+ met #crcsm new reference standard in refractory #mcrc #gi23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope